Calidi Biotherapeutics, Inc. Preferred Stock, Shares Authorized
Calidi Biotherapeutics, Inc. (CLDI) had Preferred Stock, Shares Authorized of 1.00 million shares as of 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2023-08-21
- 2023-06-30: Preferred Stock, Shares Authorized 1.00M shares.
- 2023-03-31: Preferred Stock, Shares Authorized 1.00M shares.
- 2022-12-31: Preferred Stock, Shares Authorized 1.00M shares.
- 2022-09-30: Preferred Stock, Shares Authorized 1.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2023-06-30 | 1.00M shares 10-Q · filed 2023-08-21 |
| 2023-03-31 | 1.00M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 1.00M shares 10-Q · filed 2023-08-21 |
| 2022-09-30 | 1.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 1.00M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 1.00M shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 1.00M shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 1.00M shares 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |